This transcript covers Altimmune's presentation at the Jefferies Conference, focusing on their strategic insights regarding pemvidutide. Pemvidutide is likely a pharmaceutical product or drug candidate being developed by Altimmune, and the conference presentation likely provided updates on its development, clinical trials, or market potential.
Are you the organizer?
Claim this event to edit details, see analytics, and get leads
This transcript covers Altimmune's presentation at the Jefferies Conference, focusing on their strategic insights regarding pemvidutide. Pemvidutide is likely a pharmaceutical product or drug candidate being developed by Altimmune, and the conference presentation likely provided updates on its development, clinical trials, or market potential.
Receive curated event recommendations based on your interests.
See how WebMobi helps you manage registration, check-in, and analytics.
Request a DemoOr start free βWebMobi provides event registration, ticketing, mobile apps, check-in, and analytics β all with zero platform fees.
Get curated B2B events, AI-powered insights, and industry trends delivered to your inbox